Application of “Omics” Technologies to In Vitro Toxicology

Cite This

Files in this item

Files Size Format View

There are no files associated with this item.

BALMER, Nina V., Tyna DAO, Marcel LEIST, Kinga VOIJNITS, Tanja WALDMANN, Liang ZHAO, Helena T. HOGBERG, Erwin VAN VLIET, 2014. Application of “Omics” Technologies to In Vitro Toxicology. In: ANNA BAL-PRICE ..., , ed.. In Vitro Toxicology Systems. New York:Springer, pp. 399-432. ISBN 978-1-4939-0520-1. Available under: doi: 10.1007/978-1-4939-0521-8_18

@incollection{Balmer2014Appli-30151, title={Application of “Omics” Technologies to In Vitro Toxicology}, year={2014}, doi={10.1007/978-1-4939-0521-8_18}, number={1557-2153}, isbn={978-1-4939-0520-1}, address={New York}, publisher={Springer}, series={Methods in Pharmacology and Toxicology}, booktitle={In Vitro Toxicology Systems}, pages={399--432}, editor={Anna Bal-Price ...}, author={Balmer, Nina V. and Dao, Tyna and Leist, Marcel and Voijnits, Kinga and Waldmann, Tanja and Zhao, Liang and Hogberg, Helena T. and van Vliet, Erwin} }

<rdf:RDF xmlns:dcterms="" xmlns:dc="" xmlns:rdf="" xmlns:bibo="" xmlns:dspace="" xmlns:foaf="" xmlns:void="" xmlns:xsd="" > <rdf:Description rdf:about=""> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Balmer, Nina V.</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:abstract xml:lang="eng">“Omics” technologies have facilitated significant advances in the understanding of toxicity mechanisms in complex biological systems. In this chapter we discuss the most important “omics” technologies and how they are currently applied in the field of in vitro toxicology. For each technology, advantages, limitations, and developmental needs are addressed. In addition, we provide some future prospects on the role of “omics” technologies in the emerging new paradigm of mechanistic toxicity studies. It becomes clear that technological developments have enhanced the application of “omics” technologies in toxicology and simplified the interpretation of the generated information; nevertheless, significant challenges remain to incorporate “omics” technologies and “omics” data in the regulatory decision making process.</dcterms:abstract> <dc:contributor>van Vliet, Erwin</dc:contributor> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>Zhao, Liang</dc:creator> <bibo:uri rdf:resource=""/> <dc:creator>Voijnits, Kinga</dc:creator> <dcterms:available rdf:datatype="">2015-03-04T11:00:47Z</dcterms:available> <dc:contributor>Dao, Tyna</dc:contributor> <dspace:isPartOfCollection rdf:resource=""/> <dc:date rdf:datatype="">2015-03-04T11:00:47Z</dc:date> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:contributor>Voijnits, Kinga</dc:contributor> <dc:creator>Dao, Tyna</dc:creator> <dc:contributor>Hogberg, Helena T.</dc:contributor> <dc:creator>van Vliet, Erwin</dc:creator> <dcterms:title>Application of “Omics” Technologies to In Vitro Toxicology</dcterms:title> <dc:contributor>Balmer, Nina V.</dc:contributor> <dcterms:isPartOf rdf:resource=""/> <dc:language>eng</dc:language> <dc:contributor>Waldmann, Tanja</dc:contributor> <dc:contributor>Zhao, Liang</dc:contributor> <dc:creator>Waldmann, Tanja</dc:creator> <dcterms:issued>2014</dcterms:issued> <dc:creator>Hogberg, Helena T.</dc:creator> </rdf:Description> </rdf:RDF>

This item appears in the following Collection(s)

Search KOPS


My Account